english Icono del idioma   español Icono del idioma  

Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/54958 Cómo citar
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorFerrara, Florencia-
dc.contributor.authorRial, Analía-
dc.contributor.authorSuárez, Norma-
dc.contributor.authorChabalgoity, José Alejandro-
dc.date.accessioned2026-05-12T16:05:06Z-
dc.date.available2026-05-12T16:05:06Z-
dc.date.issued2021-
dc.identifier.citationFERRARA, F., RIAL, A., SUÁREZ, N., y otros. Polyvalent Bacterial Lysate Protects Against Pneumonia Independently of Neutrophils, IL-17A or Caspase-1 Activation. Front. Immunol [en línea] 2021, 12. DOI: 10.3389/fimmu.2021.562244es
dc.identifier.urihttps://hdl.handle.net/20.500.12008/54958-
dc.description.abstractPolyvalent bacterial lysates have been in use for decades for prevention and treatment of respiratory infections with reported clinical benefits. However, besides claims of broad immune activation, the mode of action is still a matter of debate. The lysates, formulated with the main bacterial species involved in respiratory infections, are commonly prepared by chemical or mechanical disruption of bacterial cells, what is believed influences the biological activity of the product. Here, we prepared two polyvalent lysates with the same composition but different method of bacterial cell disruption and evaluated their biological activity in a comparative fashion. We found that both bacterial lysates induce NF-kB activation in a MyD88 dependent manner, suggesting they work as TLR agonists. Further, we found that a single intranasal dose of any of the two lysates, is sufficient to protect against pneumococcal pneumonia, suggesting that they exert similar biological activity. We have previously shown that protection against pneumococcal pneumonia can also be induced by prior S. pneumoniae sub lethal infection or therapeutic treatment with a TLR5 agonist. Protection in those cases depends on neutrophil recruitment to the lungs, and can be associated with increased local expression of IL-17A. Here, we show that bacterial lysates exert protection against pneumococcal pneumonia independently of neutrophils, IL-17A or Caspase-1/11 activation, suggesting the existence of redundant mechanisms of protection. Trypsin-treated lysates afford protection to the same extent, suggesting that just small peptides suffice to exert the protective effect or that the molecules responsible for the protective effect are not proteins. Understanding the mechanism of action of bacterial lysates and deciphering the active components shall allow redesigning them with more precisely defined formulations and expanding their range of action.es
dc.description.sponsorshipAgencia Nacional de Investigación e Innovación (ANII)es
dc.format.mimetypeapplication/pdfes
dc.language.isoenes
dc.relation.ispartofFront. Immunol. 12, 2021es
dc.rightsLas obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)es
dc.subjectpolyvalent bacterial lysatees
dc.subjectrespiratory tract infectionses
dc.subjectTLR stimulationes
dc.subjectpneumoniaes
dc.subjectlungses
dc.subjectIL-17Aes
dc.subjectinflammasomees
dc.titlePolyvalent Bacterial Lysate Protects Against Pneumonia Independently of Neutrophils, IL-17A or Caspase-1 Activationes
dc.typeArtículoes
dc.contributor.filiacionFerrara Florencia, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico-
dc.contributor.filiacionRial Analía, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico-
dc.contributor.filiacionSuárez Norma, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico-
dc.contributor.filiacionChabalgoity José Alejandro, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico-
dc.rights.licenceLicencia Creative Commons Atribución (CC - By 4.0)es
dc.identifier.doi10.3389/fimmu.2021.562244-
Aparece en las colecciones: Artículos - Instituto de Higiene

Ficheros en este ítem:
Fichero Descripción Tamaño Formato   
Polyvalent Bacterial Lysate Protects Against Pneumonia Independently of Neutrophils, IL-17A or Caspase-1 Activation.pdfArtículo original827,3 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons